Vimarsana
Biggest News Aggregation in the World

Page 11 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Around 1.8 million Americans received COVID shots last week -IQVIA - Vimarsana News

Around 1.8 million Americans received COVID shots last week -IQVIA

By Michael Erman (Reuters) -Around 1.8 million people in the U.S. received a COVID-19 vaccine during the week ended Sept. 22, according to data compiled by ...

Prescriptions for Ozempic and similar drugs with weight-loss effects soar past 9 million - Vimarsana News

Prescriptions for Ozempic and similar drugs with weight-loss effects soar past 9 million

Health-care providers wrote more than 9 million prescriptions for Ozempic and similar drugs in the final three months of 2022, according to a new analysis.

Commentary: Key questions about Medicare's new drug pricing - Vimarsana News

Commentary: Key questions about Medicare's new drug pricing

After months of speculation, the Centers for Medicare and Medicaid Services (known as CMS) has finally released the list of medicines that will be subject to the agency’s new price-negotiating

Lisa Jarvis: Five key questions about Medicare's new drug pricing - Vimarsana News

Lisa Jarvis: Five key questions about Medicare's new drug pricing

After months of speculation, the Centers for Medicare and Medicaid Services (known as CMS) has finally released the list of medicines that will be subject to the agency’s new price-negotiating powers. The list should give the public hope that — assuming legal challenges from drugmakers are defeated — the program could yield significant savings and […]

Column: Five key questions about Medicare's new drug pricing - Vimarsana News

Column: Five key questions about Medicare's new drug pricing

After months of speculation, the Centers for Medicare and Medicaid Services (known as CMS) has finally released the list of medicines that will be subject to the agency’s new price-negotiating